Abstract:Abstract The identification of interactions between drugs/compounds and their targets is crucial for the development of new drugs. In vitro screening experiments (i.e. bioassays) are frequently used for this purpose; however, experimental approaches are insufficient to explore novel drug-target interactions, mainly because of feasibility problems, as they are labour intensive, costly and time consuming. A computational field known as ‘virtual screening’ (VS) has emerged in the past decades to aid experimental drug discovery studies by statistically estimating unknown bio-interactions between compounds and biological targets. These methods use the physico-chemical and structural properties of compounds and/or target proteins along with the experimentally verified bio-interaction information to generate predictive models. Lately, sophisticated machine learning techniques are applied in VS to elevate the predictive performance. The objective of this study is to examine and discuss the recent applications of machine learning techniques in VS, including deep learning, which became highly popular after giving rise to epochal developments in the fields of computer vision and natural language processing. The past 3 years have witnessed an unprecedented amount of research studies considering the application of deep learning in biomedicine, including computational drug discovery. In this review, we first describe the main instruments of VS methods, including compound and protein features (i.e. representations and descriptors), frequently used libraries and toolkits for VS, bioactivity databases and gold-standard data sets for system training and benchmarking. We subsequently review recent VS studies with a strong emphasis on deep learning applications. Finally, we discuss the present state of the field, including the current challenges and suggest future directions. We believe that this survey will provide insight to the researchers working in the field of computational drug discovery in terms of comprehending and developing novel bio-prediction methods.

In silico drug discovery: a machine learning-driven systematic review

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

Streamlining Computational Fragment-Based Drug Discovery Through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening

A Systematic Literature Review of the Current Status and Future Prospects of Machine Learning Methods and Techniques Applied to Novel Drug Discovery

Emerging trends in computational approaches for drug discovery in molecular biology

The Emergence of In-Silico Models in Drug Target Interaction System: A Comprehensive Review

Role of Artificial Intelligence and Machine Learning in Sustainable Drug Discovery

Artificial intelligence: Machine learning approach for screening large database and drug discovery

Machine Learning Applications in Drug Discovery

A review on artificial intelligence and machine learning used in pharmaceutical research

Computational Methods in Drug Discovery and Development

What are the current challenges for machine learning in drug discovery and repurposing?

Implementation of an Automated System Using Machine Learning Models to Accelerate the Process of In Silico Identification of Small Molecules As Drug Candidates

Deep Learning in Virtual Screening: Recent Applications and Developments

Machine Learning Approaches and their Applications in Drug Discovery and Design

Transformative Target-Based Approaches

Recent progress on the prospective application of machine learning to structure-based virtual screening

A Comprehensive Review on Machine Learning and Deep Learning Methods in Drug Discovery

Machine learning in preclinical drug discovery

Evaluating the Impact of AI and ML on Modern Drug Discovery

Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries